MoonLake Immunotherapeutics (MLTX) Other Non-Current Assets (2023 - 2026)

MoonLake Immunotherapeutics' Other Non-Current Assets history runs 4 years deep, the most recent figure standing at $1.3 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets fell 20.85% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $1.3 million (down 20.85% YoY), while the FY2025 annual figure was $596000.0, changed N/A from the prior year.
• Other Non-Current Assets was $1.3 million for Q1 2026 at MoonLake Immunotherapeutics, up from $596000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $8.4 million in Q4 2023 to a low of $587000.0 in Q3 2025.
• Historically, Other Non-Current Assets has averaged $3.0 million across 4 years, with a median of $1.7 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Other Non-Current Assets plunged 73.13% in 2025, then retreated 20.85% in 2026.
• A 4-year view of Other Non-Current Assets shows it stood at $8.4 million in 2023, then sank by 75.49% to $2.1 million in 2024, then plunged by 71.13% to $596000.0 in 2025, then jumped by 125.5% to $1.3 million in 2026.
• The last three Other Non-Current Assets figures came in at $1.3 million (Q1 2026), $596000.0 (Q4 2025), and $587000.0 (Q3 2025), per Business Quant data.